Nano‐Strategies for Lignin Biomaterials toward Cancer Therapy

Author:

Sathasivam Thenapakiam12,Kai Jing3,Sugiarto Sigit2,Yu Yong2,Soo Debbie Xiang Yun2,Zhu Qiang24,Merzaban Jasmeen3,Kai Dan124ORCID

Affiliation:

1. Institute of Sustainability for Chemicals Energy and Environment (ISCE2) The Agency for Science, Technology and Research (A*STAR) 2 Fusionopolis Way, Innovis, #08‐03 Singapore 138634 Singapore

2. Institute of Materials Research and Engineering (IMRE) The Agency for Science Technology and Research (A*STAR) 2 Fusionopolis Way, Innovis, #08‐03 Singapore 138634 Singapore

3. Cell Migration and Signaling Laboratory Bioscience Program Division of Biological and Environmental Science and Engineering King Abdullah University of Science and Technology (KAUST) Thuwal 23955‐6900 Saudi Arabia

4. School of Chemistry, Chemical Engineering and Biotechnology Nanyang Technological University 21 Nanyang Link Singapore 637371 Singapore

Abstract

AbstractLignin is a nontoxic and biocompatible biopolymer with many promising characteristics, including a high tensile strength and antioxidant properties. This natural polymer can be processed through several chemical methods and modified into lignin nanomaterials for potential biomedical applications. This review summarizes the latest developments in nanolignin (NL)‐based biomaterials for cancer therapy; various NL applications related to cancer therapy are considered, including drug and gene delivery, biosensing, bioimaging, and tissue engineering. The manuscript also outlines the potential use of these materials to improve the therapeutic potency of chemotherapeutic drugs by decreasing their dose and reducing their adverse effects. Due to its high surface area‐to‐volume ratio and the easy modification of its chemical components, NL could serve as an appropriate matrix for the binding and controlled release of various pharmaceutical agents. Moreover, the challenges in the utilization of NL‐based materials for cancer therapy are discussed, along with the prospects of advances in such nanomaterials for medical research applications.

Funder

Connecticut Development Authority

Agency for Science, Technology and Research

Publisher

Wiley

Subject

Pharmaceutical Science,Biomedical Engineering,Biomaterials

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3